These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36628358)

  • 21. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Villar J; Soto Conti CP; Gunier RB; Ariff S; Craik R; Cavoretto PI; Rauch S; Gandino S; Nieto R; Winsey A; Menis C; Rodriguez GB; Savasi V; Tug N; Deantoni S; Fabre M; Martinez de Tejada B; Rodriguez-Sibaja MJ; Livio S; Napolitano R; Maiz N; Sobrero H; Peterson A; Deruelle P; Giudice C; Teji JS; Casale RA; Salomon LJ; Prefumo F; Cheikh Ismail L; Gravett MG; Vale M; Hernández V; Sentilhes L; Easter SR; Capelli C; Marler E; Cáceres DM; Albornoz Crespo G; Ernawati E; Lipschuetz M; Takahashi K; Vecchiarelli C; Hubka T; Ikenoue S; Tavchioska G; Bako B; Ayede AI; Eskenazi B; Thornton JG; Bhutta ZA; Kennedy SH; Papageorghiou AT;
    Lancet; 2023 Feb; 401(10375):447-457. PubMed ID: 36669520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
    Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
    Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort study.
    Karuniawati A; Pasaribu AP; Lazarus G; Irawany V; Nusantara DU; Sinto R; Suwarti ; Nasution MJ; Ferawati ; Lubis MR; Nurfitri E; Mutiara M; Arifin H; Hely H; Putri PAD; Pradipta A; Susanto AP; Kumaheri MA; Bonifacius ; Da Costa Y; Bogh C; Safari D; Lidia K; Malewa HI; Nuraeni N; Zanjabila S; Rahardjani M; Dewi FA; Wulandari F; Subekti D; Surendra H; Baird JK; Shankar AH; Hamers RL
    Lancet Reg Health Southeast Asia; 2024 Mar; 22():100348. PubMed ID: 38482150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
    Favre G; Maisonneuve E; Pomar L; Winterfeld U; Daire C; Martinez de Tejada B; Delecraz D; Campelo S; Moser M; Todesco-Bernasconi M; Sturm S; Hösli I; Monod C; Frey Tirri B; Kalimeris S; Blume C; Mathis J; Zimmerman R; Radan AP; Surbek D; Baud D; Panchaud A
    Lancet Reg Health Eur; 2022 Jul; 18():100410. PubMed ID: 35651954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
    Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 infection in pregnancy during the first wave of COVID-19 in the Netherlands: a prospective nationwide population-based cohort study (NethOSS).
    Overtoom EM; Rosman AN; Zwart JJ; Vogelvang TE; Schaap TP; van den Akker T; Bloemenkamp K
    BJOG; 2022 Jan; 129(1):91-100. PubMed ID: 34494694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study.
    Skarbinski J; Wood MS; Chervo TC; Schapiro JM; Elkin EP; Valice E; Amsden LB; Hsiao C; Quesenberry C; Corley DA; Kushi LH
    Lancet Reg Health Am; 2022 Aug; 12():100297. PubMed ID: 35756977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal and Perinatal Outcomes Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Seasely AR; Blanchard CT; Arora N; Battarbee AN; Casey BM; Dionne-Odom J; Leal SM; Moates DB; Sinkey RG; Szychowski JM; Tita AT; Subramaniam A;
    Obstet Gynecol; 2022 Aug; 140(2):262-265. PubMed ID: 35852277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    McClymont E; Albert AY; Alton GD; Boucoiran I; Castillo E; Fell DB; Kuret V; Poliquin V; Reeve T; Scott H; Sprague AE; Carson G; Cassell K; Crane J; Elwood C; Joynt C; Murphy P; Murphy-Kaulbeck L; Saunders S; Shah P; Snelgrove JW; van Schalkwyk J; Yudin MH; Money D;
    JAMA; 2022 May; 327(20):1983-1991. PubMed ID: 35499852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.
    Hyams C; Challen R; Marlow R; Nguyen J; Begier E; Southern J; King J; Morley A; Kinney J; Clout M; Oliver J; Gray S; Ellsbury G; Maskell N; Jodar L; Gessner B; McLaughlin J; Danon L; Finn A;
    Lancet Reg Health Eur; 2023 Feb; 25():100556. PubMed ID: 36530491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
    Smith H; Mahon A; Moss A; Rao S
    J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study.
    Auvigne V; Vaux S; Strat YL; Schaeffer J; Fournier L; Tamandjou C; Montagnat C; Coignard B; Levy-Bruhl D; Parent du Châtelet I
    EClinicalMedicine; 2022 Jun; 48():101455. PubMed ID: 35611065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
    Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
    JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status-United States, 1 January 2020-25 December 2021.
    Strid P; Zapata LB; Tong VT; Zambrano LD; Woodworth KR; Riser AP; Galang RR; Gilboa SM; Ellington SR
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S317-S325. PubMed ID: 35717652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea.
    Lee J; Ko M; Kim S; Lim D; Park G; Lee SE
    Osong Public Health Res Perspect; 2023 Aug; 14(4):263-271. PubMed ID: 37652681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of variants of SARS-CoV-2 on obstetrical and neonatal outcomes.
    Poisson M; Sibiude J; Mosnino E; Koual M; Landraud L; Fidouh N; Mandelbrot L; Vauloup-Fellous C; Luton D; Benachi A; Vivanti AJ; Picone O
    J Gynecol Obstet Hum Reprod; 2023 Apr; 52(4):102566. PubMed ID: 36870417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of SARS-CoV-2 Infection on Maternal and Neonatal Outcome in Correlation with Sociodemographic Aspects: A Retrospective Case-Control Study.
    Chicea R; Neagu AD; Chicea ED; Grindeanu AS; Bratu DG; Boicean AG; Roman MD; Fleacă SR; Chicea LM; Teacoe DA; Radu IA; Ognean ML
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
    Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
    Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.